Our results here suggest that GBA1 mutations alone are not sufficient to cause Parkinson’s disease, but also require an additional factor such as increased expression of alpha-synuclein (via, for example, epigenetic modifications). This evidence concerns the gene GBA1 and Parkinson disease.